You can’t put a price on life, but that isn’t stopping Swiss drugmaker Novartis from trying. The company just scored approval from the U.S. Food and Drug Administration for a new treatment that could save the lives of hundreds of babies born in the United States each year. That is, as long as their parents’ pockets are deep enough.
As NPR reports, the medication, called Zolgensma, treats a condition called spinal muscular atrophy, a genetic defect that causes a rapid deterioration in nerves that control muscles. Babies stricken with the condition lose the ability to control their limbs, and eventually weaken to the point where they can’t eat or even breathe. The drug that could save their lives with a one-time treatment is now priced at a jaw-dropping $2.125 million.
BGR Top Deals:
- Amazon’s Fire TV Stick 4K is down to the price of an entry-level Fire TV Stick
- Prime Day came early for the Apple Watch Series 4
Trending Right Now:
- This is how incredible iOS 13 might look on the iPhone 11
- The iPhone app you need to stop spam calls is on sale for free today
- Crazy sale gets you killer noise cancelling headphones for less than half as much as Beats
The FDA just approved a baby-saving drug that carries an obscene $2.1 million price tag originally appeared on BGR.com on Mon, 27 May 2019 at 11:04:54 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report